Shannon Bean, Ms Email & Phone Number

Brunswick, Me, Us

Dedicated to a comprehensive range of responsibilities that encompass the entire investment lifecycle; identifying potential deals, conducting thorough due diligence, and sealing transactions. Furthermore, nurturing of portfolio companies, providing mentorship, and shaping both strategic direction and fundraising initiatives. **If you’re a startup seeking investment or a limited partner interested in our future funds, I would love to connect!**email: shannon.bean@ceiventures.com

Langdon, Nh, Us

Provide growth strategy support.email: sbean@motheroffact.com

Us, Us

Provide growth strategy support.email: shannon@flyparrots.com

New York, New York, Us

As an Expert, I provide strategic advice and guidance to founders and operators within the Primary portfolio and broader network. Experts enjoy access to early-stage businesses, emerging trends and technology, and an expanded network of exceptional leaders and resources through a top-tier seed-stage firm.Primary is New York City’s premier early-stage venture firm working alongside founders to build unicorns like Alloy, Alma, Chief, Dandy Electric, Latch, K Health, Stellar Health, Slice, and many more.

Mountain View, Wy, Us

Creating an innovative intelligent infrastructure through Human-Computer Interaction (HCI) across multiple industries, driving growth strategy & product.

Secaucus, Nj, Us

Previously a member of Quest’s Healthcare Analytics Solutions ("HAS") Leadership Team, I was responsible for driving the formation of strategic partnerships that resulted in bringing technology, data, domain expertise, enhancements and/or channels together which were critical elements of driving the business growth strategy and product development. · Worked across five business verticals; Pharma, Clinical Trials, Provider Analytics, Health Plans, Public Health supporting the Business Unit’s P&L goals· Developed strategic roadmaps to secure new partnerships that enabled product development resulted in de-risking, accelerating and/or expanding the five businesses· Led cross-functional team (XFN) alignment (Leadership, Product Management, Program Management, Engineering, Compliance, Legal, Finance, Marketing, etc.) while selling strategic partnership vision internally and externally to partners· Generated and negotiated term sheets that resulted in streamlined inputs to the execution of contracting· Developed and negotiated strategic partnership contracting documents such as but not limited to, Master Collaboration Agreements, Product Agreements· Collaborated with the M&A team to support diligence and integration of deals pertaining/interdependent to the HAS business__________________________________________________________________________________________Healthcare Analytics Solution's mission: we provide data-backed actionable insights to address the big challenges across the healthcare and life science ecosystems.https://www.questpharmasolutions.com/pharma/healthcare-analytics-solutions/

Belfast, Northern Ireland, Gb

Directed end-to-end global (Americas, EU, APAC, ROW) business and corporate development processes by leading pre-and post-partnership activities and identifying nexus of opportunities to strategically grow and support Diaceutics’ precision medicine diagnostic business. • Produced 80+ partnership proposals (range of $100 K – $2 MM), teasers and capability presentations for clients, investors, and board of directors • Generated and negotiated contracting documents (CDA, MSA, SOW/Work Orders); resulted in $12+MM • Played a key role in supporting product launch, DXRX - the world’s first diagnostic network for precision medicine• Developed partnership strategy and execution plans to identify, target and close new business opportunities (e.g. J.P.Morgan Healthcare San Francisco 2020, Virtual ASCO 2020, etc) resulting in forged relationships across global clientele of pharma, diagnostic, and laboratories• Evaluated pharma pipelines (oncology and general medicine biomarkers), technologies, and products that represent near-term commercial opportunities and streamed-lined operations between internal and external stakeholders on project execution and transparency __________________________________________________________________________________________We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. Our products and services are focused on optimizing its clients’ strategies for the development and launch of precision medicines specifically, the diagnostic testing required to guide the selection of such medicines. Diaceutics has worked on every precision medicine brought to market and provides services to the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Lake Forest, Il, Us

Executed business development efforts to guide senior leadership in its external partnering and licensing strategies and managed ongoing business relationships with Assertio's alliance partners. Evaluated business and scientific merits of new therapeutic indications in CNS and Neurology.• Identified target partners for in- and out-licensing, M&A, or commercial partnerships. Resulted in acquisition of five marketed products from Iroko Pharmaceuticals, Inc. (Iroko); SoluMatrix® NSAIDs: VIVLODEX® (meloxicam), TIVORBEX® (indomethacin), and ZORVOLEX® (diclofenac), INDOCIN® (indomethacin) oral suspension capsules and INDOCIN suppositories• Supported M&A teams in evaluating financial feasibility of potential acquisitions using valuation analyses i.e., DCF• Steered the M&A integration process of Iroko’s products between signing and closing. Resulted in efficient and streamlined transition of products by partnering with Finance, Accounting, Commercial, Legal, Manufacturing & Supply Chain, QA, Clinical & Regulatory, Medical Affairs and PV, IP, Compliance, and Leadership teams to ensure milestones and issues were raised • Managed relationships with alliance partners for SPRIX® (ketorolac tromethamine), OraPharma and Ascend Therapeutics to ensure partners were on track to meet contractual obligations and milestones • Evaluated business and scientific merits of new therapeutic indications • Evaluated Vendor contracts and supported negotiations for vendor consolidation and management• Led planning for key partnering conferences; BIO Boston 2018, BioEurope Denmark 2018 and JPMorgan Chase San Francisco 2019• Led efforts in preparing data rooms for reverse due diligence

Rochester, New York, Us

(Formerly, High Tech Rochester) Managed the NYSERDA EIR Program under Governor Andrew Cuomo’s administration, a statewide mentoring program for companies in various stages. Evaluated 35+ life science, clean-energy, and tech companies across NYS and provided operational management support to scale.• Managed strategic partnerships with NYSERDA, university accelerators, companies and EIRs• Increased business development efforts by a factor of 3X, engaging with various stakeholders across the entrepreneurial ecosystems in the US• Led and managed 60 EIRs and 35+ companies following a strategic vetting process implemented to sustain ultimate goal; a world class EIR program• Accelerated company growth by connecting EIRs with new companies in short-term, highly focused strategic and consulting engagements• Developed and negotiated engagement contracts and produced quarterly and annual reports for Governor Cuomo's administration

Rochester, New York, Us

Multifaceted role actively in the management of deal flow, due-diligence investment negotiations for over 50 life science, health, SaaS, clean energy, and tech investment opportunities. • Made investment recommendations to managing partners resulting in over $1.2MM total investments as either convertible debt or equity • Advised panel discussions of entrepreneurs connected to various universities • Assisted companies who were in deep due diligence with strategic direction, business development and P&L forecast models• Assigned as relationship builder at events/meetings to develop regional and national partnerships for the firm in upstate New York • Trained junior analysts by directing new hires in performing due diligence; led to increased efficiency, effective evaluations and investment direction

Bar Harbor, Me, Us

Conducted research on the genetic basis of aging and age-associated kidney disease using both C. elegans and mouse model systems under Drs. Ron Korstanje and George Sutphin. • Co-authored “Caenorhabditis elegans orthologs of human genes differently expressed with age are enriched for determinants of longevity” in Aging Cell (2017) pp1-11, Doi:10.1111/acel.12595 • Managed and analyzed data for verbal/written presentations and publications • Maintained animals, harvested tissue samples for analysis and utilized molecular techniques such as PCR/western blotting

New Brunswick, Nj, Us

Ortho Clinical Diagnostics part of the J+J umbrella of companies: Oversaw validation of CellSearch, a Circulating Tumor Cell (CTC) test product, currently used in monitoring patients with metastatic breast, colorectal and prostate cancer. Managed and executed hemolysis investigations on the THERAKOS CELLEX Photopheresis System, currently used by academic medical centers, hospitals, and treatment centers around the world treating over one million people from skin manifestations of cutaneous T-cell lymphoma. • Assisted in product development and troubleshooting protocols - product sales for the CTC platform reached over $30MM in 2014• Maintained primary mammalian cell culture on PC39 and SkBr3 cells• Presented findings to Director of R&D that contributed in product launch

Bar Harbor, Me, Us

Investigated the genetic basis for immune tolerance to endogenous proteins and the defects in these mechanisms that lead to type I diabetes.• Presented findings to over 200 people including the President and CEO, leadership team, trustees, donors and other prestigious individuals • Participated in cultivation events and formed meaningful relationships with trustees and JAX National Council• Managed experimental mice and common isolation techniques (e.g., dendritic cells isolation)

Master Of Science (M.S.), Service Leadership & Innovation, Concentration: Entrepreneurship & Service Systems

The Roux Institute At Northeastern University, Graduate Certificate In Applied Analytics

Bachelor Of Science (B.S.), Biotechnology